Figure 1.
![Anti-CMV T-cell activity and clinical response in patients treated with CMV-specific VSTs for active CMV infection. (A) Anti-CMV antigen (phosphoprotein 65 [PP65], immediate early protein-1 [IE1]) T-cell response of the CMV-specific VST products as detected by IFN-γ ELISpot assay. Anti-CMV antigen T-cell response and CMV viral load (IU or copies per milliliter) in the recipient PB post-VST infusion for patient P4, P5, P7 treated with CMV infection (B-D) and timing of concomitant standard antiviral treatment. PCR, polymerase chain reaction; SFU, spot forming units.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/10/10.1182_bloodadvances.2022008219/1/blooda_adv-2022-008219-gr1.jpeg?Expires=1723159289&Signature=PJg78O5~ktc21T~w39gjmk5wZf6Z2e1JJe6v3GRwAxGsSt9dx014JF~9osAUGCouyzLF2QfwDyNqr84Ru3~NTyFBlaSUHLi5caS31m3R57q6pmbgx~VOgCXIvpLhW233TOoVQ9KVXiZnJtd9ASYHr-GyK11I1xpTCWl-gko0WWdwonQBrrU8NlhcykkaPOWvgPl0UMcDbYvEQ5dxahEZKOUGy3CgxFwenvTmDkmeVGKjnvuNnP5DfMc8EZ2-WABQrMhMvDgJ59pcM-tm3fKaaoZ3VsOTtHl-sAPJOuGLgt9dOODXonwDLD~4NRdbCZz3soyCQhMK1VpXiMXYNhZR2g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Anti-CMV T-cell activity and clinical response in patients treated with CMV-specific VSTs for active CMV infection. (A) Anti-CMV antigen (phosphoprotein 65 [PP65], immediate early protein-1 [IE1]) T-cell response of the CMV-specific VST products as detected by IFN-γ ELISpot assay. Anti-CMV antigen T-cell response and CMV viral load (IU or copies per milliliter) in the recipient PB post-VST infusion for patient P4, P5, P7 treated with CMV infection (B-D) and timing of concomitant standard antiviral treatment. PCR, polymerase chain reaction; SFU, spot forming units.
